Edwards Lifesciences Corp has a consensus price target of $79.59 based on the ratings of 23 analysts. The high is $105 issued by Mizuho on April 11, 2024. The low is $60 issued by Wolfe Research on January 16, 2025. The 3 most-recent analyst ratings were released by Truist Securities, Barclays, and Canaccord Genuity on April 11, 2025, February 13, 2025, and February 13, 2025, respectively. With an average price target of $78.67 between Truist Securities, Barclays, and Canaccord Genuity, there's an implied 11.27% upside for Edwards Lifesciences Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/11/2025 | Buy Now | 6.08% | Truist Securities | Richard Newitter73% | $78 → $75 | Maintains | Hold | Get Alert |
02/13/2025 | Buy Now | 27.3% | Barclays | Matt Miksic67% | $88 → $90 | Maintains | Overweight | Get Alert |
02/13/2025 | Buy Now | 0.42% | Canaccord Genuity | William Plovanic56% | $68 → $71 | Maintains | Hold | Get Alert |
02/12/2025 | Buy Now | 20.23% | RBC Capital | Shagun Singh56% | $85 → $85 | Reiterates | Outperform → Outperform | Get Alert |
02/12/2025 | Buy Now | 3.25% | Piper Sandler | Adam Maeder63% | $70 → $73 | Maintains | Neutral | Get Alert |
02/12/2025 | Buy Now | 3.25% | Evercore ISI Group | Vijay Kumar49% | $75 → $73 | Maintains | In-Line | Get Alert |
02/12/2025 | Buy Now | 6.08% | Morgan Stanley | Patrick Wood49% | $70 → $75 | Maintains | Equal-Weight | Get Alert |
01/30/2025 | Buy Now | 27.3% | Stifel | Rick Wise72% | $75 → $90 | Upgrade | Hold → Buy | Get Alert |
01/16/2025 | Buy Now | -15.13% | Wolfe Research | Mike Polark54% | $60 → $60 | Downgrade | Peer Perform → Underperform | Get Alert |
12/16/2024 | Buy Now | 27.3% | B of A Securities | Travis Steed59% | $82 → $90 | Upgrade | Neutral → Buy | Get Alert |
12/11/2024 | Buy Now | 17.4% | Citigroup | Joanne Wuensch74% | $81 → $83 | Maintains | Buy | Get Alert |
12/05/2024 | Buy Now | 27.3% | Goldman Sachs | David Roman35% | $81 → $90 | Maintains | Buy | Get Alert |
12/05/2024 | Buy Now | 10.33% | Truist Securities | Richard Newitter73% | $70 → $78 | Reiterates | Hold → Hold | Get Alert |
12/05/2024 | Buy Now | 6.08% | Stifel | Rick Wise72% | $70 → $75 | Maintains | Hold | Get Alert |
12/05/2024 | Buy Now | 20.23% | RBC Capital | Shagun Singh56% | $80 → $85 | Maintains | Outperform | Get Alert |
12/05/2024 | Buy Now | -3.82% | Canaccord Genuity | William Plovanic56% | $63 → $68 | Maintains | Hold | Get Alert |
12/02/2024 | Buy Now | 24.47% | Barclays | Matt Miksic67% | $85 → $88 | Maintains | Overweight | Get Alert |
11/27/2024 | Buy Now | 13.15% | RBC Capital | Shagun Singh56% | $75 → $80 | Maintains | Outperform | Get Alert |
10/25/2024 | Buy Now | -10.89% | Canaccord Genuity | William Plovanic56% | $66 → $63 | Maintains | Hold | Get Alert |
10/25/2024 | Buy Now | 10.33% | JP Morgan | Robbie Marcus66% | $72 → $78 | Maintains | Neutral | Get Alert |
10/25/2024 | Buy Now | -0.99% | Piper Sandler | Adam Maeder63% | $73 → $70 | Maintains | Neutral | Get Alert |
10/25/2024 | Buy Now | -0.99% | Truist Securities | Richard Newitter73% | $71 → $70 | Maintains | Hold | Get Alert |
10/25/2024 | Buy Now | -3.82% | Baird | David Rescott60% | $73 → $68 | Maintains | Neutral | Get Alert |
10/11/2024 | Buy Now | -0.99% | Morgan Stanley | Patrick Wood49% | → $70 | Reinstates | → Equal-Weight | Get Alert |
10/08/2024 | Buy Now | 6.08% | RBC Capital | Shagun Singh56% | $85 → $75 | Maintains | Outperform | Get Alert |
10/07/2024 | Buy Now | -6.65% | Canaccord Genuity | William Plovanic56% | $77 → $66 | Maintains | Hold | Get Alert |
10/01/2024 | Buy Now | -0.99% | Evercore ISI Group | Vijay Kumar49% | $76 → $70 | Maintains | In-Line | Get Alert |
10/01/2024 | Buy Now | 8.91% | Citigroup | Joanne Wuensch74% | $83 → $77 | Maintains | Buy | Get Alert |
09/18/2024 | Buy Now | -0.99% | Jefferies | Matthew Taylor70% | $85 → $70 | Downgrade | Buy → Hold | Get Alert |
09/13/2024 | Buy Now | 0.42% | Truist Securities | Richard Newitter73% | $82 → $71 | Maintains | Hold | Get Alert |
09/12/2024 | Buy Now | 27.3% | Oppenheimer | Suraj Kalia54% | $90 → $90 | Maintains | Outperform | Get Alert |
09/10/2024 | Buy Now | 6.08% | UBS | Danielle Antalffy60% | $90 → $75 | Maintains | Neutral | Get Alert |
09/09/2024 | Buy Now | 13.15% | Barclays | Matt Miksic67% | $90 → $80 | Maintains | Overweight | Get Alert |
09/09/2024 | Buy Now | 13.15% | Wells Fargo | Larry Biegelsen66% | $90 → $80 | Maintains | Overweight | Get Alert |
07/29/2024 | Buy Now | — | Wolfe Research | Mike Polark54% | — | Upgrade | Underperform → Peer Perform | Get Alert |
07/26/2024 | Buy Now | 27.3% | Barclays | Matt Miksic67% | $101 → $90 | Maintains | Overweight | Get Alert |
07/26/2024 | Buy Now | 28.71% | Goldman Sachs | David Roman35% | $107 → $91 | Maintains | Buy | Get Alert |
07/25/2024 | Buy Now | -0.99% | TD Cowen | Joshua Jennings54% | $100 → $70 | Downgrade | Buy → Hold | Get Alert |
07/25/2024 | Buy Now | 27.3% | Wells Fargo | Larry Biegelsen66% | $99 → $90 | Maintains | Overweight | Get Alert |
07/25/2024 | Buy Now | 7.5% | Evercore ISI Group | Vijay Kumar49% | $91 → $76 | Maintains | In-Line | Get Alert |
07/25/2024 | Buy Now | 20.23% | Deutsche Bank | Pito Chickering67% | $103 → $85 | Maintains | Buy | Get Alert |
07/25/2024 | Buy Now | 20.23% | RBC Capital | Shagun Singh56% | $101 → $85 | Maintains | Outperform | Get Alert |
07/25/2024 | Buy Now | 15.98% | Truist Securities | Richard Newitter73% | $110 → $82 | Downgrade | Buy → Hold | Get Alert |
07/25/2024 | Buy Now | -0.99% | Stifel | Rick Wise72% | $85 → $70 | Maintains | Hold | Get Alert |
07/25/2024 | Buy Now | 27.3% | Oppenheimer | Suraj Kalia54% | $100 → $90 | Maintains | Outperform | Get Alert |
07/25/2024 | Buy Now | 8.91% | Canaccord Genuity | William Plovanic56% | $85 → $77 | Maintains | Hold | Get Alert |
07/25/2024 | Buy Now | 3.25% | Piper Sandler | Adam Maeder63% | $88 → $73 | Maintains | Neutral | Get Alert |
07/25/2024 | Buy Now | 6.08% | B of A Securities | Travis Steed59% | $105 → $75 | Downgrade | Buy → Neutral | Get Alert |
07/25/2024 | Buy Now | 1.84% | JP Morgan | Robbie Marcus66% | $105 → $72 | Downgrade | Overweight → Neutral | Get Alert |
07/25/2024 | Buy Now | -0.99% | Baird | David Rescott60% | $102 → $70 | Downgrade | Outperform → Neutral | Get Alert |
07/16/2024 | Buy Now | 55.59% | Truist Securities | Richard Newitter73% | $105 → $110 | Maintains | Buy | Get Alert |
07/10/2024 | Buy Now | 49.93% | Citigroup | Joanne Wuensch74% | $105 → $106 | Maintains | Buy | Get Alert |
07/02/2024 | Buy Now | 28.71% | Evercore ISI Group | Vijay Kumar49% | $89 → $91 | Maintains | In-Line | Get Alert |
05/30/2024 | Buy Now | 51.34% | Goldman Sachs | David Roman35% | → $107 | Initiates | → Buy | Get Alert |
05/22/2024 | Buy Now | 48.51% | Citigroup | Joanne Wuensch74% | $98 → $105 | Upgrade | Neutral → Buy | Get Alert |
05/14/2024 | Buy Now | 45.69% | Deutsche Bank | Pito Chickering67% | $86 → $103 | Upgrade | Hold → Buy | Get Alert |
05/07/2024 | Buy Now | 42.86% | Barclays | Matt Miksic67% | $100 → $101 | Maintains | Overweight | Get Alert |
04/26/2024 | Buy Now | 20.23% | Canaccord Genuity | William Plovanic56% | $86 → $85 | Maintains | Hold | Get Alert |
04/26/2024 | Buy Now | 40.03% | Wells Fargo | Larry Biegelsen66% | $94 → $99 | Maintains | Overweight | Get Alert |
04/26/2024 | Buy Now | 25.88% | Evercore ISI Group | Vijay Kumar49% | $92 → $89 | Maintains | In-Line | Get Alert |
04/26/2024 | Buy Now | 20.23% | Stifel | Rick Wise72% | $83 → $85 | Maintains | Hold | Get Alert |
04/26/2024 | Buy Now | 24.47% | Piper Sandler | Adam Maeder63% | $85 → $88 | Maintains | Neutral | Get Alert |
04/15/2024 | Buy Now | 42.86% | RBC Capital | Shagun Singh56% | $95 → $101 | Maintains | Outperform | Get Alert |
04/11/2024 | Buy Now | 48.51% | Mizuho | Anthony Petrone64% | $95 → $105 | Maintains | Buy | Get Alert |
04/04/2024 | Buy Now | 30.13% | Evercore ISI Group | Vijay Kumar49% | $86 → $92 | Maintains | In-Line | Get Alert |
04/03/2024 | Buy Now | 38.61% | Citigroup | Joanne Wuensch74% | $90 → $98 | Maintains | Neutral | Get Alert |
03/26/2024 | Buy Now | — | OTR Global | — | — | Upgrade | Mixed → Positive | Get Alert |
03/21/2024 | Buy Now | 45.69% | Morgan Stanley | Patrick Wood49% | $95 → $103 | Maintains | Overweight | Get Alert |
03/18/2024 | Buy Now | 41.44% | Oppenheimer | Suraj Kalia54% | $93 → $100 | Maintains | Outperform | Get Alert |
03/07/2024 | Buy Now | — | B of A Securities | Travis Steed59% | — | Upgrade | Neutral → Buy | Get Alert |
02/07/2024 | Buy Now | 17.4% | Stifel | Rick Wise72% | $70 → $83 | Maintains | Hold | Get Alert |
02/07/2024 | Buy Now | 34.37% | Morgan Stanley | Patrick Wood49% | $80 → $95 | Maintains | Overweight | Get Alert |
02/07/2024 | Buy Now | 34.37% | RBC Capital | Shagun Singh56% | $82 → $95 | Maintains | Outperform | Get Alert |
02/07/2024 | Buy Now | 34.37% | Mizuho | Anthony Petrone64% | $85 → $95 | Maintains | Buy | Get Alert |
02/02/2024 | Buy Now | 32.96% | Wells Fargo | Larry Biegelsen66% | → $94 | Upgrade | Equal-Weight → Overweight | Get Alert |
01/12/2024 | Buy Now | 15.98% | RBC Capital | Shagun Singh56% | $80 → $82 | Maintains | Outperform | Get Alert |
01/04/2024 | Buy Now | 8.91% | Evercore ISI Group | Vijay Kumar49% | $80 → $77 | Downgrade | Outperform → In-Line | Get Alert |
12/22/2023 | Buy Now | 18.81% | Truist Securities | Richard Newitter73% | $78 → $84 | Maintains | Buy | Get Alert |
12/11/2023 | Buy Now | 10.33% | Truist Securities | Richard Newitter73% | $76 → $78 | Maintains | Buy | Get Alert |
12/11/2023 | Buy Now | — | Citigroup | Joanne Wuensch74% | — | Downgrade | Buy → Neutral | Get Alert |
12/04/2023 | Buy Now | 13.15% | Morgan Stanley | Patrick Wood49% | $102 → $80 | Maintains | Overweight | Get Alert |
11/28/2023 | Buy Now | -19.38% | Wolfe Research | Mike Polark54% | → $57 | Downgrade | Peer Perform → Underperform | Get Alert |
10/26/2023 | Buy Now | -0.99% | Stifel | Rick Wise72% | $87 → $70 | Maintains | Hold | Get Alert |
10/26/2023 | Buy Now | 20.23% | Mizuho | Anthony Petrone64% | $90 → $85 | Maintains | Buy | Get Alert |
10/26/2023 | Buy Now | 7.5% | Truist Securities | Richard Newitter73% | $83 → $76 | Maintains | Buy | Get Alert |
10/26/2023 | Buy Now | 15.98% | RBC Capital | Shagun Singh56% | $86 → $82 | Maintains | Outperform | Get Alert |
10/26/2023 | Buy Now | -3.82% | Piper Sandler | Adam Maeder63% | $83 → $68 | Maintains | Neutral | Get Alert |
10/26/2023 | Buy Now | 20.23% | Citigroup | Joanne Wuensch74% | $94 → $85 | Maintains | Buy | Get Alert |
10/26/2023 | Buy Now | 6.08% | Wells Fargo | Larry Biegelsen66% | $88 → $75 | Maintains | Equal-Weight | Get Alert |
10/16/2023 | Buy Now | 6.08% | Leerink Partners | Mike Kratky64% | → $75 | Initiates | → Market Perform | Get Alert |
10/02/2023 | Buy Now | 32.96% | Citigroup | Joanne Wuensch74% | $110 → $94 | Maintains | Buy | Get Alert |
09/26/2023 | Buy Now | 27.3% | Oppenheimer | Suraj Kalia54% | → $90 | Upgrade | Perform → Outperform | Get Alert |
09/08/2023 | Buy Now | 17.4% | Piper Sandler | Adam Maeder63% | $88 → $83 | Maintains | Neutral | Get Alert |
08/17/2023 | Buy Now | 35.79% | RBC Capital | Shagun Singh56% | → $96 | Reiterates | Outperform → Outperform | Get Alert |
08/01/2023 | Buy Now | 35.79% | RBC Capital | Shagun Singh56% | → $96 | Reiterates | Outperform → Outperform | Get Alert |
07/27/2023 | Buy Now | 44.27% | Morgan Stanley | Patrick Wood49% | $102 → $102 | Reiterates | Overweight → Overweight | Get Alert |
07/27/2023 | Buy Now | 35.79% | RBC Capital | Shagun Singh56% | → $96 | Reiterates | Outperform → Outperform | Get Alert |
07/27/2023 | Buy Now | 41.44% | JP Morgan | Robbie Marcus66% | $95 → $100 | Maintains | Overweight | Get Alert |
07/25/2023 | Buy Now | 51.34% | Jefferies | Matthew Taylor70% | $103 → $107 | Maintains | Buy | Get Alert |
07/19/2023 | Buy Now | 48.51% | Truist Securities | Richard Newitter73% | $101 → $105 | Maintains | Buy | Get Alert |
The latest price target for Edwards Lifesciences (NYSE:EW) was reported by Truist Securities on April 11, 2025. The analyst firm set a price target for $75.00 expecting EW to rise to within 12 months (a possible 6.08% upside). 62 analyst firms have reported ratings in the last year.
The latest analyst rating for Edwards Lifesciences (NYSE:EW) was provided by Truist Securities, and Edwards Lifesciences maintained their hold rating.
The last upgrade for Edwards Lifesciences Corp happened on January 30, 2025 when Stifel raised their price target to $90. Stifel previously had a hold for Edwards Lifesciences Corp.
The last downgrade for Edwards Lifesciences Corp happened on January 16, 2025 when Wolfe Research changed their price target from $60 to $60 for Edwards Lifesciences Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Edwards Lifesciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Edwards Lifesciences was filed on April 11, 2025 so you should expect the next rating to be made available sometime around April 11, 2026.
While ratings are subjective and will change, the latest Edwards Lifesciences (EW) rating was a maintained with a price target of $78.00 to $75.00. The current price Edwards Lifesciences (EW) is trading at is $70.70, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.